T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.1% |
| 2 | Technology | 17.78% |
| 3 | Consumer Discretionary | 15.32% |
| 4 | Financials | 14.61% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
LKQ Corp
LKQ
$6.43B
| $16.4M | ﹤0.01% |
516,945
-36
| -0% | -$1.2K |
|
1277
Polaris
PII
$3.94B
| $16.4M | ﹤0.01% |
162,074
+130,336
| +411% | +$14.6M |
|
1278
Sabre
SABR
$892M
| $16.3M | ﹤0.01% |
625,713
+508
| +0.1% | +$13K |
|
|
APTX
1279
DELISTED
Aptinyx Inc. Common Stock
APTX
| $16.3M | ﹤0.01% |
563,096
+11,796
| +2% | +$287K |
|
1280
Diageo
DEO
$53.1B
| $16.2M | ﹤0.01% |
114,494
+1,371
| +1% | +$197K |
|
|
APLS
1281
DELISTED
Apellis Pharmaceuticals
APLS
| $16.2M | ﹤0.01% |
910,559
-51,124
| -5% | -$945K |
|
1282
Globe Life
GL
$14.1B
| $16.2M | ﹤0.01% |
186,507
-17,073
| -8% | -$1.47M |
|
1283
RingCentral
RNG
$5.31B
| $16M | ﹤0.01% |
171,887
+148,566
| +637% | +$12.8M |
|
1284
Zions Bancorporation
ZION
$10.6B
| $15.9M | ﹤0.01% |
317,490
-3,881
| -1% | -$205K |
|
|
PF
1285
DELISTED
Pinnacle Foods, Inc.
PF
| $15.9M | ﹤0.01% |
244,778
-1,505,661
| -86% | -$99.6M |
|
1286
Sprott Physical Gold and Silver Trust
CEF
$8.25B
| $15.7M | ﹤0.01% |
1,346,600
+286,900
| +27% | +$3.44M |
|
1287
AES
AES
$10.5B
| $15.7M | ﹤0.01% |
1,121,096
| – | – |
|
1288
Empire State Realty Trust
ESRT
$829M
| $15.6M | ﹤0.01% |
937,339
-24,221
| -3% | -$413K |
|
1289
Howmet Aerospace
HWM
$114B
| $15.5M | ﹤0.01% |
921,186
+7,433
| +0.8% | +$118K |
|
|
MRTX
1290
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.4M | ﹤0.01% |
328,024
+115,559
| +54% | +$6.43M |
|
1291
Pinnacle West Capital
PNW
$12.3B
| $15.4M | ﹤0.01% |
194,927
-11,111
| -5% | -$892K |
|
1292
Liberty Broadband Class A
LBRDA
$5.25B
| $15.3M | ﹤0.01% |
181,685
+56
| +0% | +$4.46K |
|
1293
Everest Group
EG
$14.1B
| $15.3M | ﹤0.01% |
66,808
+1,322
| +2% | +$296K |
|
|
ECHO
1294
EchoStar
ECHO
$26.5B
| $15.2M | ﹤0.01% |
405,441
-44,041
| -10% | -$1.68M |
|
|
AUTL
1295
Autolus Therapeutics
AUTL
$548M
| $15.2M | ﹤0.01% |
502,761
+2,761
| +0.6% | +$74.5K |
|
|
OSG
1296
DELISTED
Overseas Shipholding Group Inc.
OSG
| $15.1M | ﹤0.01% |
4,790,798
-338,930
| -7% | -$1.18M |
|
1297
Unum
UNM
$14.8B
| $15M | ﹤0.01% |
383,825
| – | – |
|
|
DESP
1298
DELISTED
Despegar.com
DESP
| $15M | ﹤0.01% |
888,369
-296,131
| -25% | -$5.54M |
|
1299
BorgWarner
BWA
$14B
| $14.8M | ﹤0.01% |
394,077
-130,618
| -25% | -$5.13M |
|
1300
Comfort Systems
FIX
$62.5B
| $14.6M | ﹤0.01% |
259,686
-5,177
| -2% | -$277K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.